Daicel Arbor Biosciences

AcceGen Biotech proudly develops innovative technologies for the pharmaceutical, biotech and specialty ingredients markets. We are committed to supplying the best products and services with global manufacturing, development expertise and advanced technologies to enhance the overall quality of life.

AcceGen Biotech developed significant expertise in cell and genomic research. We provide a variety of high-quality human/animal cells, cell media/kits, cell-derived molecular biology products, gene-based assay kits, Clones, Fish probes and Sequencing products for research use.

AcceGen Biotech offers custom cell line generation, microRNA sponges and microRNA Agomir/Antagomir services to simplify the gene research. The aim is to accelerate scientific discovery related to genetic analysis available to academic researchers as well as commercial enterprises.

AcceGen Biotech has permanent facilities in Fairfield (New Jersey). We take care of our customers and their global, regional or local requirements. We welcome potential partners and distributors to explore our business all over the world.

We are a reliable, self-sustaining computational chemistry company. We offer our software and expertise to both smaller biotech companies and big pharma, either as a CRO or as licensed software, for use in the preclinical stages of drug discovery.

Are you a biotech kicking off a new project, looking for rational computer-aided drug design (CADD) to accelerate your hit discovery? We use our own software tools and a structure-based approach to identify novel small molecules targeting any protein family.

Do you need diverse comp. chem. expertise, but only employ a small in-house team, or no team at all? When you hire us as a CRO, we source our entire team’s experience in areas including structure-based design, chemoinformatics, quantum mechanics, and molecular dynamics.

Do you struggle with third-party software, hidden license requirements, and missing features? We develop our own software for most applications, precluding the need to sign other agreements or to procure other tools. We can also adjust and enhance our procedures to accommodate different project workflows. Our software works on PC, Linux, and Mac and we will run demos and workshops.

Are you looking for a long-term partner with flexibility in how you collaborate? We construct our agreements on FFS or FTE bases and generally do not retain IP on your projects. We conduct feasibility studies before spending time and money on projects that are unlikely to be successful. We will provide reports, communicate regularly, and return any generated data.

James Talton, CEO of Alchem Laboratories says, “We reviewed multiple software packages and MFI ranked in the top 10. Adding in their service and expertise made them an excellent partner on our DOD project. We’re excited by the results thus far and will absolutely continue working with their team in the future.

Contact us to start your project today! Don't forget to follow us on Twitter @MolForecaster!
Find our testimonials and references on our website!

Princeton Separations, Inc. (PSI) is a privately-owned, manufacturing-based biotechnology company specializing in molecular separations. PSI manufactures various successful products including:

Whether you need Centri·SepTM, Centri·Sep 8TM, and Centri·Sep 96TM for dye terminator removal from DNA sequencing reactions; Centri·SpinTM products for cleanup of molecular labeling reactions from nucleic acids, proteins or carbohydrates; PCR·96TM for probe and nucleotide cleanup of PCR reactions; BAC and Big BAC preparation in gene mapping, molecular cytometry and cell imaging; Modified Sequencing Grade Endopeptidases for protein sequencing and 5 BMT activator for chemical DNA\RNA synthesis; Fluoro·SpinTM labeling and purification kits for generation and purification of fluorescent probes for proteomics and drug discovery; or Pro·Spin product line for antibody purification, we have the answer for you when it comes to molecular separations!

PSI is a registered manufacturer with the FDA and the DEA. It maintains GMP (Good Manufacturing Practice) production in a growing facility in Freehold, New Jersey, where it performs sterile manufacturing for pharmaceutical/diagnostic companies.

RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radio-labeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology.

RadioMedix is introducing the SmartMedix™ automated laboratory system for synthesis of PET tracers for the research and clinical markets. RadioMedix has also established two service facilities for academic and industrial partners: cGMP Manufacturing Suite for clinical probe development and Molecular Imaging Facility for evaluation of agents in animal models.

Texas BioGene Inc. (TBG) is a global molecular diagnostics company dedicated to the development, manufacture and marketing of nucleic acid testing kits and services. Founded in Texas, USA (1999), TBG is one of the leading providers of quality HLA Typing Kits for immune matching of bone marrow, cord blood and solid organ transplants. TBG has instituted a comprehensive quality control system and is an ISO13485 accredited manufacturer of medical devices including CE approved typing kits. Currently TBG has R&D, manufacturing and sales operations in the US, Taiwan and China.

Due to it's unparalleled performance in immune matching ability, nucleic acid testing is becoming an essential tool in helping the clinician with critical transplant decisions. TBG is continually pushing to the forefront of nucleic acid testing for diagnostics. From the extraction of nucleic acids, amplification and detection of infectious diseases, genotyping and viral load testing, TBG is commited to expanding the applications of our core technology. To this end TBG's EZbead Systems for automated nucleic acid extraction based on magnetic bead technology have been introduced to help make nucleic acid diagnostics accessible to laboratories worldwide.